- Home
- Apac Implantable Ports Market

APAC Implantable Ports Market - Industry Trends and Forecast to 2030
- Published Date: October, 2023 | Report ID: CLS-2012 | No of pages: 127 | Format:
The Asia-Pacific implantable ports market is expected to reach USD 169,892.81 thousand by 2030 from USD 104,806.18 thousand in 2022, growing at a CAGR of 6.2% during the forecast period of 2023 to 2030.
Market Segmentation
Asia-Pacific Implantable Ports Market, By Type (Single Lumen, Double Lumen, and Power-Injectable), Material (Polyurethane, Silicone, Titanium, and Others), Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, and Others), End Users (Hospitals, Clinics, Ambulatory Surgical Centre, Dialysis Centers, and Others), Country (China, Japan, India, Australia & New Zealand, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, and Rest of Asia Pacific) - Industry Trends and Forecast to 2030
Overview of Asia-Pacific Implantable Ports Market Dynamics
Drivers
• Increasing prevalence of chronic diseases
• Growing demand for minimally invasive procedures
Restraint
• Risk of infections and mechanical complications
Opportunity
• Rising demand for implantable port devices due to a high success rate
Market Players
Some of the major market players operating in the Asia-Pacific implantable ports market are:
• B. Braun SE
• AngioDynamics
• BD
• Teleflex Incorporated
• ICU Medical, Inc.
• Districlass Médical
• PakuMedmedical products gmbh
TABLE OF CONTENT
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 OVERVIEW OF THE ASIA PACIFIC IMPLANTABLE PORTS MARKET 13
1.4 CURRENCY AND PRICING 14
1.5 LIMITATIONS 14
1.6 MARKETS COVERED 14
2 MARKET SEGMENTATION 16
2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 Cognate Lifesciences TRIPOD DATA VALIDATION MODEL 19
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.6 MULTIVARIATE MODELLING 23
2.7 TYPE SEGMENT LIFELINE CURVE 23
2.8 MARKET END USERS COVERAGE GRID 24
2.9 Cognate Lifesciences MARKET POSITION GRID 25
2.10 VENDOR SHARE ANALYSIS 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 30
4.1 CONSUMER BUYING BEHAVIOUR 33
4.2 FACTORS AFFECTING BUYING DECISION 33
4.3 PRODUCT ADOPTION SCENARIO 33
4.4 REGULATION COVERAGE 34
4.5 BRAND ANALYSIS 36
4.6 RAW MATERIAL SOURCING ANALYSIS 37
4.7 IMPORT EXPORT SCENARIO 37
4.8 PORTER'S 5 FORCES 39
5 SUPPLY CHAIN ANALYSIS 40
5.1 LOGISTIC COSTS SCENARIO 40
5.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS 40
6 MARKET OVERVIEW 42
6.1 DRIVERS 44
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 44
6.1.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 44
6.1.3 INCREASING ONCOLOGY AND CHEMOTHERAPY PROCEDURES 45
6.1.4 IMPROVED DEVICE DESIGN AND FUNCTIONALITY 45
6.2 RESTRAINTS 46
6.2.1 RISK OF INFECTIONS AND MECHANICAL COMPLICATIONS 46
6.2.2 STRINGENT REGULATORY REQUIREMENTS FOR APPROVAL PROCESS 46
6.3 OPPORTUNITIES 47
6.3.1 RISING DEMAND FOR IMPLANTABLE PORT DEVICES DUE TO HIGH SUCCESS RATE 47
6.3.2 EXPANSION OF HOME-BASED HEALTHCARE 47
6.4 CHALLENGES 48
6.4.1 LACK OF SKILLED PROFESSIONALS OR EXPERTISE 48
6.4.2 PRODUCT RECALL OF IMPLANTABLE PORT DEVICES 48
7 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY TYPE 50
7.1 OVERVIEW 51
7.2 SINGLE LUMEN 54
7.3 DOUBLE LUMEN 54
7.4 POWER- INJECTABLE 55
8 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY MATERIAL 56
8.1 OVERVIEW 57
8.2 POLYURETHANE 60
8.3 SILICONE 60
8.4 TITANIUM 61
8.5 OTHERS 62
9 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY APPLICATION 63
9.1 OVERVIEW 64
9.2 CHEMOTHERAPY 67
9.3 BLOOD TRANSFUSION 67
9.4 ANTIBIOTICS 68
9.5 INTRAVENOUS INFUSION OF BLOOD PRODUCT 69
9.6 PAIN MANAGEMENT 69
9.7 OTHERS 70
10 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY END USERS 71
10.1 OVERVIEW 72
10.2 HOSPITALS 75
10.3 CLINICS 75
10.4 AMBULATORY SURGICAL CENTER 76
10.5 DIALYSIS CENTER 76
10.6 OTHERS 78
11 ASIA PACIFIC IMPLANTABLE PORTS MARKET, BY REGION 79
11.1 ASIA-PACIFIC 80
11.1.1 CHINA 86
11.1.2 JAPAN 88
11.1.3 INDIA 90
11.1.4 AUSTRALIA & NEW ZEALAND 92
11.1.5 SOUTH KOREA 94
11.1.6 INDONESIA 96
11.1.7 PHILIPPINES 98
11.1.8 THAILAND 100
11.1.9 MALAYSIA 102
11.1.10 SINGAPORE 104
11.1.11 REST OF ASIA-PACIFIC 106
12 ASIA PACIFIC IMPLANTABLE PORTS MARKET: COMPANY LANDSCAPE 107
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 107
13 SWOT 108
14 ASIA PACIFIC IMPLANTABLE PORTS MARKET, COMPANY PROFILE 109
14.1 B.BRAUN SE 109
14.1.1 COMPANY SNAPSHOT 109
14.1.2 COMPANY SHARE ANALYSIS 109
14.1.3 PRODUCT PORTFOLIO 110
14.1.4 RECENT DEVELOPMENTS 110
14.2 ANGIODYNAMICS 111
14.2.1 COMPANY SNAPSHOT 111
14.2.2 REVENUE ANALYSIS 111
14.2.3 COMPANY SHARE ANALYSIS 112
14.2.4 PRODUCT PORTFOLIO 112
14.2.5 RECENT DEVELOPMENT 112
14.3 BD 113
14.3.1 COMPANY SNAPSHOT 113
14.3.2 REVENUE ANALYSIS 113
14.3.3 COMPANY SHARE ANALYSIS 114
14.3.4 PRODUCT PORTFOLIO 114
14.3.5 RECENT DEVELOPMENT 114
14.4 TELEFLEX INCORPORATED 115
14.4.1 COMPANY SNAPSHOT 115
14.4.2 REVENUE ANALYSIS 115
14.4.3 COMPANY SHARE ANALYSIS 116
14.4.4 PRODUCT PORTFOLIO 116
14.4.5 RECENT DEVELOPMENTS 116
14.5 VYGON 117
14.5.1 COMPANY SNAPSHOT 117
14.5.2 COMPANY SHARE ANALYSIS 117
14.5.3 PRODUCT PORTFOLIO 118
14.5.4 RECENT DEVELOPMENT 118
14.6 AMI GMBH 119
14.6.1 COMPANY SNAPSHOT 119
14.6.2 PRODUCT PORTFOLIO 119
14.6.3 RECENT DEVELOPMENT 119
14.7 DISTRICLASS MÉDICAL 120
14.7.1 COMPANY SNAPSHOT 120
14.7.2 PRODUCT PORTFOLIO 120
14.7.3 RECENT DEVELOPMENT 120
14.8 ICU MEDICAL, INC. 121
14.8.1 COMPANY SNAPSHOT 121
14.8.2 REVENUE ANALYSIS 121
14.8.3 PRODUCT PORTFOLIO 122
14.8.4 RECENT DEVELOPMENT 122
14.9 PAKUMEDMEDICAL PRODUCTS GMBH 123
14.9.1 COMPANY SNAPSHOT 123
14.9.2 PRODUCT PORTFOLIO 123
14.9.3 RECENT DEVELOPMENTS 123
15 QUESTIONNAIRE 124
16 RELATED REPORTS 127
Segmentation
Short Description
Asia-Pacific Implantable Ports Market, By Type (Single Lumen, Double Lumen, and Power-Injectable), Material (Polyurethane, Silicone, Titanium, and Others), Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, and Others), End Users (Hospitals, Clinics, Ambulatory Surgical Centre, Dialysis Centers, and Others), Country (China, Japan, India, Australia & New Zealand, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, and Rest of Asia Pacific) - Industry Trends and Forecast to 2030
Market Definition
The Asia-Pacific implantable ports market is the worldwide market for medical devices known as implantable ports. These devices are used in healthcare settings to facilitate repeated access to a patient's bloodstream to deliver medications, fluids, or blood products and for blood sampling. Implantable ports consist of two main components: a reservoir or chamber that is surgically implanted beneath the skin, usually in the chest or upper arm, and a catheter that connects the reservoir to a large vein, typically the subclavian vein or jugular vein. The catheter remains inside the patient's body, providing a stable access point for medical professionals to administer treatments or perform diagnostic procedures.
Market Segmentation
The Asia-Pacific implantable ports market is segmented into four notable segments based on type, material, application, and end users.
• On the basis of type, the market is segmented into single lumen, double lumen, and power-injectable
• On the basis of material, the market is segmented into polyurethane, silicone, titanium, and others
• On the basis of application, the market is segmented into chemotherapy, blood transfusion, antibiotics, intravenous infusion of blood product, pain management, and others
• On the basis of end users, the market is segmented into hospitals, clinics, ambulatory surgical center, dialysis centers, and others
Market Players
Some of the major market players operating in the Asia-Pacific implantable ports market are:
• B. Braun SE
• AngioDynamics
• BD
• Teleflex Incorporated
• Vygon
• ICU Medical, Inc.
• Districlass Médical
• PakuMedmedical products gmbh
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.